Baxter Prepares To Launch TachoSil Surgical Sealant For Cardiac Surgery
This article was originally published in The Gray Sheet
Executive SummaryBaxter plans a U.S. launch of TachoSil, a first-of-its-kind absorbable fibrin sealant patch for use in cardiovascular surgery, in the second half of 2010, following FDA approval of the combination device-biologic April 2
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.